Industry Insights
How Science Is Helping To Solve the Food Waste Crisis
Industry InsightIn this article, we look at some of the innovations being used to give food waste new life around the world.
Read More
What Does the Fourth Industrial Revolution Mean for Research?
Industry InsightLabVantage Solutions, Inc., a provider of laboratory informatics software solutions, has signaled a turn towards the future with its appointment of digital transformation veteran Mikael Hagstroem as its new chief executive officer. We spoke to Mikael to find out more.
Read More
Next-Generation Sequencing for SARS-CoV-2 Surveillance
Industry InsightTo gain some insights into the role of NGS in global SARS-CoV-2 surveillance, we spoke to Michelle Fraser, general manager, NGS for PerkinElmer. Michelle also explains how labs working in this area can increase their throughput, decrease associated costs and simplify the analysis of NGS data collected.
Read More
ABP-300: A Neutralizing Antibody Treatment for COVID-19
Industry InsightTechnology Networks recently had the pleasure of speaking with Abpro’s CEO, Ian Chan, to learn more about the company’s research and development pipeline. Chan discusses in detail the development of ABP-300, a monoclonal antibody that neutralizes SARS-CoV-2 by associating with the virus’s spike protein.
Read More
Advancing Research of Inflammatory Intestinal Diseases
Industry InsightWe spoke to Dr Lorna Ewart, Emulate’s executive vice president of science, to learn more about the limitations of traditional inflammatory intestinal disease models, what makes the Colon Intestine-Chip a more relevant model and how it can be used to investigate potential drug targets.
Read More
Harnessing T Cells To Detect Disease
Industry InsightIn this interview, Dr Sudeb Dalai, senior medical director at Adaptive Biotechnologies, discusses the role that T-cell analysis may play in the diagnosis and treatment of diseases including SARS-CoV-2.
Lateral Flow Assay Development
Industry InsightHere we summarize the webinar that was hosted by Klaus Hochleitner, PhD., which provides an overview of the important factors and considerations for robust lateral flow assay development.
Read More
Detecting Residual Cancer Using Whole-Genome Sequencing and Artificial Intelligence
Industry InsightWhen a tumor is surgically removed, small amounts of residual cancer can remain at a level that is undetectable with current imaging or blood-based approaches. In this interview, Technology Networks spoke with Asaf Zviran, co-founder and CEO of C2i Genomics to find out more about the company’s C2-Intelligence Platform for the detection of trace amounts of cancer.
Read More
Minipig Study Tests Gene Therapy for Huntington's Disease
Industry InsightA new body of work published in Science Translational Medicine outlines the preclinical testing of a microRNA-based gene therapy for Huntington's disease – AMT-130 – in minipigs.
Read More
Bioprocessing and Bioproduction Trends in Cell and Gene Therapies
Industry InsightIn this interview, Technology Networks spoke with Neal Goodwin, PhD, Chief Scientific Officer at Teknova, to learn more about current bioprocessing and bioproduction trends in the cell and gene therapy space. Goodwin also discusses the impact of the COVID-19 pandemic on the biopharmaceutical sector and highlights how the industry has united to contribute to the development of vaccines at this critical time.
Read More
